# Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

> **NCT04876846** · NA · COMPLETED · sponsor: **Raydiant Oximetry, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Fetal Hypoxia

## Interventions

- **DEVICE:** GEN 3 Monitoring of Fetus

## Key facts

- **NCT ID:** NCT04876846
- **Lead sponsor:** Raydiant Oximetry, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-24
- **Primary completion:** 2025-11-11
- **Final completion:** 2025-11-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04876846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04876846, "Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04876846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*